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The discovery that tissue plasminogen activator can
promote neuronal degeneration has uncovered a novel
pathway leading to neuronal cell death and raises
important issues concerning the use of tissue
plasminogen activator as a thrombolytic therapy
for stroke.
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Ischemic stroke is one of the most common causes of
neurological damage in humans and is usually the result of
a clot blocking one of the blood vessels supplying the
brain. Clots are broken down by plasmin, which is gener-
ated from its inactive precursor, plasminogen, by tissue
plasminogen activator (tPA). Clot-busting therapy using
tPA, if administered within three hours of an ischemic
stroke, appears to benefit patients [1]. Recent observa-
tions on tPA-deficient mice, however, suggest that the use
of tPA as a thrombolytic agent in stroke therapy might be
a double-edged sword [2]. 
While re-establishing blood flow in ischemic regions will
certainly help reduce neuronal cell death, the work of
Strickland’s group [2] raises concerns that exogenously
administered tPA may be partly responsible for killing
neurons too. Although, in humans, the balance already
appears to favour the early use of thrombolytic therapy,
the issues raised by the new findings need to be
addressed. Apart from the immediate clinical considera-
tions, work on the tPA-deficient mice has shed new light
on wholly novel pathways which may contribute to
neuronal degeneration.
What is excitotoxicity?
The death of neurons is central to most pathologies of the
central nervous system (CNS) and, as there is little scope
for regeneration in the CNS, neuronal degeneration is
responsible for lasting disability. Developing strategies to
protect neurons from injury is thus likely to be of benefit
in a wide variety of neurodegenerative conditions. To
develop such strategies, we need a better understanding
of the processes that lead to neuronal cell death. 
Neuronal cell death is observed after excessive excitation
of ionotrophic glutamate receptors by glutamate or related
amino acids and has given rise to the ‘excitotoxicity
hypothesis’ [3]. Within the CNS, it is mainly glutamate
that mediates fast excitatory neurotransmission. Normally,
released glutamate is quickly cleared from the extra-cellu-
lar space by energy-dependent processes, and the neurons
are left uninjured. However, in situations where excessive
glutamate is released and uptake mechanisms have been
compromised, as may happen during an ischemic event in
the brain, exposure to glutamate can be neurotoxic.
There are three main subtypes of ionotrophic glutamate-
gated channels, which have been named according to their
preferred agonist: N-methyl-D-aspartate (NMDA),
kainate, and α-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionate (AMPA). In vivo, kainate is far more potent than
glutamate when it comes to inducing excitotoxicity in the
normal brain, because it is not cleared as rapidly as gluta-
mate. The NMDA receptors, however, are thought to be
the principal mediators of excitotoxicity, as they are per-
meable to Na+, K+ and Ca2+ ions. Only a small subset of
AMPA or kainate channels are permeable to Ca2+ ions, a
property that has been shown to be critical for rapid-onset
excitotoxicity in vitro. Indeed, the activation of kainate
receptors is thought to result in secondary activation of the
NMDA receptors, as experiments with antagonists have
demonstrated that blockade of both NMDA and
AMPA/kainate receptors is required to prevent rapid-
onset, kainate-induced cell death.
According to the excitotoxicity hypothesis, glutamate
receptor activation to neuronal cell death is thought to
take the following path: receptor activation leads to Na+
influx to the neuron; voltage-gated Ca2+ channels open in
response to Na+ influx; intra-cellular Ca2+ levels rise and
the cells physically swell; and lastly, there is inappropriate
activation of many Ca2+-dependent catabolic processes
that result in neuronal cell death by a mixture of apoptosis
and necrosis [4]. Clearly, the jump from Ca2+ influx to cell
death is a big one, and it is one that remains poorly
understood. Interest has centred on the activation of intra-
neuronal Ca2+-dependent proteases (such as the calpains
[5]), endonucleases [6], phospholipases [7] and caspases
[8], and on the generation of free radicals [9]. Few
researchers have considered that there might be extra-
neuronal processes involved.
The proteolytic cascade hypothesis
The observations of Strickland and colleagues over the
past few years look likely to establish a role for extra-neu-
ronal processes in excitotoxicity (Figure 1). They found
that ‘knockout’ mice lacking tPA are resistant to excito-
toxin-mediated hippocampal neuronal degeneration [10].
tPA is produced primarily by microglia, the down-regulated
resident macrophages of the brain. As mentioned above,
tPA converts plasminogen to plasmin, which in turn
degrades fibrin, fibronectin and laminin. Plasmin also
processes many of the matrix-degrading metalloproteinases
from pro-forms to active-forms. Thus, the observations on
the tPA-deficient mouse implicate an extracellular prote-
olytic cascade in excitotoxin-induced cell death and suggest
that microglia are important in the degeneration process.
To demonstrate that the resistance observed in the tPA-
deficient knockout mice is unlikely to be a consequence
of abnormal postnatal development, tPA was infused bilat-
erally into the hippocampus of the mutant mice, which
were then injected with kainate [11]. In the presence of
kainate and tPA, hippocampal neurons degenerated, but
no degeneration was observed in the opposite hemi-
sphere. Furthermore, 3H-kainate binding to the hippo-
campus in tPA-deficient mice was indistinguishable from
wild-type mice, indicating that the same number of recep-
tors are present [12].
It remained unclear, however, whether the substrate for
tPA in the brain is, as expected, plasminogen. In a further
set of experiments, Tsirka et al. [12] went on to show that
mice deficient for plasminogen are also resistant to
excitotoxic injury. Interestingly, tPA-deficient mice
exhibit attenuated microglial activation, as determined by
unaltered levels of F4/80 surface antigen, as a reaction to
kainate-induced neuronal injury. In contrast, the
microglial response of plasminogen-deficient mice is
comparable to that of wild-type mice, suggesting the
existence of a tPA-mediated, plasminogen-independent
pathway for activation of microglia.
The resistance to excitotoxic injury of plasminogen-
deficient mice implies that substrates of the enzyme’s
product plasmin are likely to be important components of
excitotoxicity. Fibrin looks unlikely to be the plasminogen
substrate that mediates excitotoxicity, as fibrinogen
knockout mice are still susceptible to kainate-induced
excitotoxicity [12]. Further evidence for the involvement
of a proteolytic cascade in excitotoxicity comes from
inhibitor studies. Inhibitors of tPA (plasminogen activator
inhibitor) [11] and plasmin (α2-antiplasmin) [12] have
both been shown to inhibit kainate-induced excitotoxicity
in wild-type mice. Although Strickland and colleagues
have focused their studies on the hippocampus, our own
studies suggest a more general applicability; α2-antiplas-
min will reduce kainate-induced cell death in the striatum
of the rat (unpublished observations).
The case for microglial involvement in excitotoxicty has
been strengthened by the recent observations that
macrophage inhibitory factor (MIF) will also block excito-
toxin-induced neuronal cell death [13]. Microglial cells in
the presence of MIF, infused into the hippocampus, fail
to become activated following injection of kainate — as
they normally would [14] — and produce less tPA in
response to lipopolysaccharide (a further treatment that
normally stimulates microglia activation). The data thus
implicate microglia as being key players in excitotoxic
cell death.
How do activated microglia cause neuronal cell death? It
is known that such cells, within inflammatory lesions in
the brain, synthesise matrix metalloproteinases [15]. This
family of endopeptidases, which contain Zn2+ at the
active site and are Ca2+-dependent, are able to degrade all
of the components of the extracellular matrix [16], and
can process the precursor of the inflammatory cytokine
tumour necrosis factor-α (TNF-α) to its mature, soluble
form [17]. Direct injection of highly purified matrix met-
alloproteinases — such as gelatinase-A, gelatinase-B or
matrilysin — into the striatum of rats results in demyeli-
nation and neuronal cell death [18]. The mechanism by
which this is achieved is unknown, but we have shown
that gelatinase-B is extensively expressed within acute
stroke lesions [15]. In all the cases we examined, there
was a marked infiltration of gelatinase-B-positive neu-
trophils and some macrophages within the infarcted
tissue. There was also increased expression of both gelati-
nase-A and matrilysin within the chronic stroke lesions,
and this persists for up to five years after the original
ischemic event. Their presence in the chronic lesions
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Figure 1
The proteolytic cascade hypothesis. Excitotoxins, acting through
glutamate receptors, provoke the release of tPA from activated
microglia and neurons. The released tPA is then able to convert
inactive plasminogen to plasmin. Plasmin, in turn, can degrade laminin
and activate the ‘pro’ forms of the matrix metalloproteinases, which are
synthesised by microglia. Disruption of laminin–neuron interactions
results in neuronal degeneration. Excessive matrix metalloproteinase
release may be cytotoxic in itself or, as is more likely, may cause
neuronal degeneration by disrupting the extracellular matrix.
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suggests that there might be on-going neuronal degenera-
tion long after a stroke.
Both plasmin and many of the matrix metallopro-
teinases, including matrilysin, can degrade laminin. In
studies by Chen and Strickland [19], where the expres-
sion of various extracellular proteins before and after
excitotoxic lesions was examined, it was found that
laminin may be of critical importance in excitoxicity.
Their principal findings were as follows. First, laminin
disappears rapidly after the injection of excitotoxin and
before neuronal loss. Second, tPA-deficient mice display
minimal laminin loss following kainate injection. And
third, anti-laminin antibody injection, which interferes
with neuron–laminin interactions, leads to neuronal
degeneration in the absence of tPA. As the anti-laminin
antibodies caused neuronal degeneration, rather than
just promoting it, these results suggest that disruption of
the extracellular environment of a neuron is enough to
cause degeneration. 
It would be interesting to know whether the phenomenon
observed by Chen and Strickland [19] is specific to
laminin–neuron interactions, or whether the disruption or
degradation of other extracellular matrix proteins might
also result in neuronal cell death. The extracellular matrix
of the adult brain tissue has a unique composition in that
the typical matrix proteins, such as collagen, are nearly
absent. Instead, the brain extracellular matrix is mainly
composed of lecticans, which are proteoglycans containing
a lectin domain and a hyaluronic-acid-binding domain
[20]. Thus, the disruption of the various lectican–neuron
interactions might also result in neuronal degeneration.
Therapeutic implications
Clearly, the proteolytic cascade hypothesis of neuronal
cell death suggests novel strategies for therapeutic inter-
vention. Inhibitors of plasmin/tPA, of microglial activa-
tion, and of matrix metalloproteinases may all have
practical therapeutic potential. However, consideration of
the implications for existing stroke therapy is more
urgent. Thrombolytic therapy for acute ischemic stroke
has been approached cautiously, because there were high
rates of intracerebral haemorrhage in early clinical trials.
If the therapy is administered outside the three-hour
window, a dramatic increase in the risk of intracerebral
haemorrhage is present. Even if the therapy is given
within three hours of the ischemic event, a small increase
in the rate of intracerebral haemorrhage has been noted
[1]. As tPA is involved in the cascade that processes pro-
matrix metalloproteinases to the active forms, the admin-
istration of tPA at a time when the number of
matrix-metalloproteinase-expressing leucocytes is
increasing might be significant in activating and promot-
ing the destructive potential of these enzymes, thereby
leading to haemorrhage. 
The recent observations of Strickland and colleagues now
suggest that administration of tPA to stroke patients might
not only increase the risk of haemorrhage but, on entering
the CNS, might potentiate neuronal degeneration.
Indeed, Wang et al. [2] have shown that tPA infused into
wild-type mice will increase the size of an ischemic lesion.
Although it is tempting to extrapolate to the clinical situa-
tion, we should remember that pre-clinical studies in
stroke therapy have not readily translated to the clinic.
However, the development of new tPA-based throm-
bolytic drugs, which are active only at the site of the clot,
might be of benefit.
The experiments described above draw attention to some
new areas of investigation. Now, the role of the tPA
cascade, the nature of the proteases that are activated,
and the nature of their substrates all need to be defined.
The new studies also add further weight to the evidence
that microglia are directly involved in neuronal cell death.
The dementia associated with AIDS has been linked to
the neurotoxic substances secreted by HIV-1-infected
microglia [21]. Furthermore, in the developing CNS, the
secretion of nerve growth factor (NGF) by microglia
might be neurotoxic [22]. Finally, the unusual extracellu-
lar matrix of the CNS has been implicated in the regener-
ative response of the CNS [23] , but these experiments
indicate that it might be involved in the modulation of
neuronal activity.
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If you found this dispatch interesting, you might also want
to read the October 1997 issue of
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Neurobiology
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using green fluorescent protein chimeras
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Glia, neurons, and axon pathfinding during optic
chiasm development
Carol A Mason and David W Stretavan
Myelin glycolipids and their functions
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the same issue also included the following
reviews, edited by Joseph T Coyle and
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transplantation and regeneration:
Pathological mutations of nicotinic receptors and
nicotine-based therapies for brain disorders
Clément Léna and Jean-Pierrs Changeux
Neurobiology of schizophrenia
Michael F Egan and Daniel R Weinberger
The biological basis of autism
Joseph Piven
Molecular mechanisms of opiate and cocaine addiction
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The full text of Current Opinion in Neurobiology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/nrb
